Clinical Policy in Progress

Updated on: December 19, 2025

Please note: the ACC uses a January - December calendar, which is indicated in the estimated release dates below. The policies appear in order based on their estimated release date.

Topic Estimated Release Date
Clinical Practice Guidelines (ACC/AHA)
Acute Pulmonary Embolism 2026 Quarter 1
Dyslipidemia (formerly Cholesterol) 2026 Quarter 1
Cardiovascular Kidney Metabolic Syndrome 2026 Quarter 2
Primary Prevention of Cardiovascular Disease 2026 Quarter 4
Valvular Heart Disease 2027 Quarter 1
Pulmonary Hypertension 2027 Quarter 1
Performance Measures (ACC/AHA)
Peripheral Artery Disease 2026 Quarter 1
Atrial Fibrillation 2026 Quarter 4
Expert Consensus Decision Pathways
Optimizing Postpartum Care for Women With or At-Risk of CVD 2026 Quarter 1
Resistant Hypertension Monitoring and Management 2026 Quarter 2
HFpEF (Update of 2023) 2026 Quarter 3
The Role of Nonstatin Lipid Lowering Therapies in ASCVD Risk Management (Update) 2026 Quarter 4
Systems of Care
Operator and Institutional Requiremnents for Tricuspid Regurgitation 2026 Quarter 1
Concise Clinical Guidance
ECG Screening in Student Athletes 2026 Quarter 1
Navigating Pediatric Left to Right Shunt Lesions 2026 Quarter 1
Adult Immunization as Part of CV Care (Update of 2025) 2026 Quarter 1
Advanced CV Risk Detection and Assessment 2026 Quarter 2
Shared Decision Making 2026 Quarter 3
Scientific Statements
Lipid Management 2026 Quarter 1
Gene Editing 2026 Quarter 1
Cardiovascular Care of the Tactical Athlete 2026 Quarter 1
Antiplatelet Therapy in Primary and Secondary Prevention of CVD 2026 Quarter 2
Appropriate Use Criteria
Coronary Revascularization 2026 Quarter 2
Aortic Stenosis (Update of 2017 AUC) 2026 Quarter 3
Competence and Training Statements
Advanced Training Statement on Clinical Cardiac Electrophysiology (Update of 2015) 2026 Quarter 2
Advanced Training Statement on Critical Care Cardiology 2026 Quarter 3
Advanced Training Statement on Adults with Congenital Heart Disease 2026 Quarter 4